Stage 3 · Toolkit 3.2
Drug Substance Development & Control Strategy
Define drug substance development, process controls, impurities, CQAs, and CPPs.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Drug Substance Development & Control Strategy.
How it helps your team
Keep CMC evidence, changes, and release decisions visible as development moves forward.
Designed for
CMC, Pharmaceutical Development, Manufacturing, Quality, Supply Chain, and Regulatory Affairs teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Drug Substance Development Plan
- Manufacturing Process Description Template
- Starting Material Justification Template
- Impurity Strategy Template
- Control Strategy Template
- Drug Substance Key Finding Summary
Excel workbooks
- Drug Substance Development Tracker
- Critical Quality Attribute Tracker
- Critical Process Parameter Tracker
- Impurity Tracker
- Drug Substance Evidence Matrix
Related toolkits
Continue within stage 3
CMC Development & Regulatory Readiness
Govern CMC development, evidence readiness, and regulatory preparation.
3.3Drug Product / Formulation Development
Define formulation, excipient, container closure, and drug product control strategy.
3.4Analytical Method Development & Validation
Govern analytical methods, validation, transfer, lifecycle, and deviations.